Noble Financial analyst Joe Gomes maintained a Hold rating on MustGrow Biologics (MGROF – Research Report) today. The company’s shares closed yesterday at $0.77.
According to TipRanks, Gomes is a 4-star analyst with an average return of 6.0% and a 43.99% success rate. Gomes covers the Industrials sector, focusing on stocks such as Orion Group Holdings, Geo Group, and DLH Holdings.
The analyst consensus on MustGrow Biologics is currently a Hold rating.
MGROF market cap is currently $38.49M and has a P/E ratio of -10.43.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
MustGrow Biologics (MGROF) Company Description:
MustGrow Biologics Corp is a company engaged in the development of natural biopesticide products from mustard seed. It is focused on the development and commercialization of non-synthetic AITC (Allyl Isothiocyanate) from mustard seed for use as a natural biofumigant for control of nematodes, soil-borne diseases, and other soil pests.
Read More on MGROF:
